✦ LIBER ✦

Treatment of Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation or ALK Gene Rearrangement: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

✍ Scribed by Gridelli, Cesare; de Marinis, Filippo; Cappuzzo, Federico; Di Maio, Massimo; Hirsch, Fred R.; Mok, Tony; Morgillo, Floriana; Rosell, Rafael; Spigel, David R.; Yang, James Chih-Hsin; Ciardiello, Fortunato

Book ID: 122229357
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 229 KB
Volume: 15
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2013.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance treatment of advanced non-sm

Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

✍ Gridelli, Cesare; de Marinis, Filippo; Di Maio, Massimo; Ardizzoni, Andrea; Bela 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Association of epidermal growth factor r

Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer

✍ Ryotaro Morinaga; Isamu Okamoto; Yoshihiko Fujita; Tokuzo Arao; Masaru Sekijima; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Recent issues in first-line treatment of

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

✍ Gridelli, Cesare; Ardizzoni, Andrea; Douillard, Jean-Yves; Hanna, Nasser; Manego 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Multicentre prospective phase II trial o

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

✍ Tamura, K; Okamoto, I; Kashii, T; Negoro, S; Hirashima, T; Kudoh, S; Ichinose, Y 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

✍ G. de Lima Lopes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

9118 POSTER Prospective Assesment of Com

9118 POSTER Prospective Assesment of Combined Pemetrexed and Erlotinib or Gefitinib Therapy After the Relapse to Erlotinib or Gefitinib in Patients With Advanced Non-Small Cell Lung Cancer Having an Active Epidermal Growth Factor Receptor Mutation

✍ Okishio, K.; Yoshimura, N.; Kimura, T.; Daga, H.; Takeda, K.; Kawaguchi, T.; Kob 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB